Physician profile
Logan Williams
NPI 1811348048
$1,604.40
in general payments reported to CMS, 2019-2025
15 companies · $334 in 2025
The $334 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.79 · 2020: $65.10 · 2021: $12.59 · 2022: $363 · 2023: $465 · 2024: $330 · 2025: $334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,128.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $413.94 | 2019-2025 | Bexsero, Pediarix, Rotarix |
| Corium, LLC | $291.93 | 2022-2025 | Azstarys |
| Pfizer INC. | $203.14 | 2022-2025 | |
| Sanofi Pasteur INC. | $180.78 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $139.71 | 2021-2025 | Gardasil 9, Vaxneuvance, Enflonsia |
| Sanofi-Aventis U.S. LLC | $78.83 | 2024-2025 | |
| Seqirus USA INC | $65.87 | 2022-2025 | Flucelvax, Flucelvax Quadrivalent |
| Astrazeneca Pharmaceuticals LP | $48.32 | 2023-2024 | Flumist Quadrivalent |
| Ironshore Pharmaceuticals INC. | $47.03 | 2022-2023 | Jornay Pm |
| Takeda Pharmaceuticals U.S.A., INC. | $35.08 | 2019-2020 | |
| Nestle Healthcare Nutrition INC. | $28.43 | 2023 | |
| Ucb, INC. | $28.21 | 2024 | Briviact |
| Tris Pharma INC | $18.50 | 2020 | |
| Adlon Therapeutics L.P. | $12.58 | 2020 | |
| Sobi, INC | $12.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Logan Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.